Sun-Young Park

Title: Sun-Young Park: Innovator in Adenosine Receptor Antagonist Compounds

Introduction

Sun-Young Park is a notable inventor based in Hwaseong-si, South Korea. He has made significant contributions to the field of pharmacology, particularly in the development of adenosine receptor antagonist compounds. His work has implications for various therapeutic applications, including cancer treatment and neurodegenerative diseases.

Latest Patents

Sun-Young Park holds a patent for adenosine receptor antagonist compounds. This patent includes compositions that feature these compounds and methods for their use in modulating A2A and/or A1 receptors in biological systems. The compounds are particularly relevant for therapeutic applications in treating cancer and conditions related to the central nervous system, such as Parkinson's disease. He has 1 patent to his name.

Career Highlights

Park is currently associated with Ildong Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His research focuses on the development of compounds that can effectively target adenosine receptors, which play a crucial role in various biological processes.

Collaborations

Some of his notable coworkers include Yoon-Suk Lee and Sung-Wook Kwon. Their collaborative efforts contribute to the advancement of research in the field of pharmacology.

Conclusion

Sun-Young Park's work in developing adenosine receptor antagonist compounds showcases his commitment to advancing medical science. His contributions have the potential to impact the treatment of serious health conditions, making him a significant figure in the field of innovation.